Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Peripheral blood telomere content is greater in patients with endometriosis than in controls.

Dracxler RC, Oh C, Kalmbach K, Wang F, Liu L, Kallas EG, Giret MT, Seth-Smith ML, Antunes D, Keefe DL, Abrao MS.

Reprod Sci. 2014 Dec;21(12):1465-71. doi: 10.1177/1933719114527353.

PMID:
24675987
2.

Immune senescence and cancer in elderly patients: results from an exploratory study.

Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S, Soldà C, Fiduccia P, Lonardi S, Zanchetta M, Keppel S, Brunello A, Zafferri V, Manzato E, De Rossi A, Zagonel V.

Exp Gerontol. 2013 Dec;48(12):1436-42. doi: 10.1016/j.exger.2013.09.011.

3.

Telomere dysfunction: a potential cancer predisposition factor.

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR.

J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8.

PMID:
12928346
4.

Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Terry KL, Tworoger SS, Vitonis AF, Wong J, Titus-Ernstoff L, De Vivo I, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):504-12. doi: 10.1158/1055-9965.EPI-11-0867.

5.

Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing.

Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A.

Exp Gerontol. 2003 Jun;38(6):653-9.

PMID:
12814800
6.

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

Wolf D, Rumpold H, Koppelstätter C, Gastl GA, Steurer M, Mayer G, Gunsilius E, Tilg H, Wolf AM.

Cancer Immunol Immunother. 2006 Oct;55(10):1198-208.

PMID:
16362412
7.

Alternative lengthening of telomeres in cancer stem cells in vivo.

Bojovic B, Booth RE, Jin Y, Zhou X, Crowe DL.

Oncogene. 2015 Jan 29;34(5):611-20. doi: 10.1038/onc.2013.603.

8.

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease.

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821.

PMID:
21912072
9.

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.

J Clin Oncol. 2004 May 15;22(10):1807-14.

PMID:
15143073
10.

Telomere length and the risk of lung cancer.

Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH, Park JY.

Cancer Sci. 2008 Jul;99(7):1385-9. doi: 10.1111/j.1349-7006.2008.00831.x.

11.

Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia.

Qi A, Zhou H, Zhou Z, Huang X, Ma L, Wang H, Yang Y, Zhang D, Li H, Ren R, Yang R.

J Clin Immunol. 2013 Apr;33(3):577-85. doi: 10.1007/s10875-012-9848-z.

PMID:
23239407
12.

Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.

Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang Y, Li T, Shi Y, Wei S, Nie S.

PLoS One. 2014 Feb 3;9(2):e88135. doi: 10.1371/journal.pone.0088135.

13.

Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.

Broberg K, Björk J, Paulsson K, Höglund M, Albin M.

Carcinogenesis. 2005 Jul;26(7):1263-71.

PMID:
15746160
14.

Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.

Wu K, Lund M, Bang K, Thestrup-Pedersen K.

Cancer. 1999 Sep 15;86(6):1056-63.

PMID:
10491534
15.

Telomere length and telomerase activity during oocyte maturation and early embryo development in mammalian species.

Ozturk S, Sozen B, Demir N.

Mol Hum Reprod. 2014 Jan;20(1):15-30. doi: 10.1093/molehr/gat055. Review.

PMID:
23928157
16.

Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition.

Cafueri G, Parodi F, Pistorio A, Bertolotto M, Ventura F, Gambini C, Bianco P, Dallegri F, Pistoia V, Pezzolo A, Palombo D.

PLoS One. 2012;7(4):e35312. doi: 10.1371/journal.pone.0035312.

17.

Development of retinoblastoma in the absence of telomerase activity.

Gupta J, Han LP, Wang P, Gallie BL, Bacchetti S.

J Natl Cancer Inst. 1996 Aug 21;88(16):1152-7.

PMID:
8757195
18.

Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

Invernizzi P, Bernuzzi F, Lleo A, Pozzoli V, Bignotto M, Zermiani P, Crosignani A, Battezzati PM, Zuin M, Podda M, Raggi C.

Dig Liver Dis. 2014 Apr;46(4):363-8. doi: 10.1016/j.dld.2013.11.008.

PMID:
24378524
19.

Telomere dynamics and homeostasis in a transmissible cancer.

Ujvari B, Pearse AM, Taylor R, Pyecroft S, Flanagan C, Gombert S, Papenfuss AT, Madsen T, Belov K.

PLoS One. 2012;7(8):e44085. doi: 10.1371/journal.pone.0044085.

20.

Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Wang F, Yin Y, Ye X, Liu K, Zhu H, Wang L, Chiourea M, Okuka M, Ji G, Dan J, Zuo B, Li M, Zhang Q, Liu N, Chen L, Pan X, Gagos S, Keefe DL, Liu L.

Cell Res. 2012 Apr;22(4):757-68. doi: 10.1038/cr.2011.201.

Items per page

Supplemental Content

Support Center